Related Experiment Video
Updated: Feb 4, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Classical pediatric Hodgkin lymphoma in very young patients: the Italian experience
Piero Farruggia1, Giuseppe Puccio2, Francesco Locatelli3
1a Pediatric Hematology and Oncology Unit Oncology Department , A.R.N.A.S. Ospedali Civico Di Cristina e Benfratelli , Palermo , Italy.
Insights
Younger children with classic Hodgkin lymphoma (cHL) have better outcomes. An age cutoff of 7 years identified low-risk pediatric patients, though age wasn't an independent factor.
Area of Science:
- Pediatric Oncology
- Hematology
- Cancer Research
Background:
- Younger patients with Hodgkin lymphoma (HL) often exhibit more favorable outcomes.
- Identifying specific age-related risk factors is crucial for optimizing pediatric cancer treatment.
Purpose of the Study:
- To determine an optimal age cutoff for identifying low-risk pediatric patients with classic Hodgkin lymphoma (cHL).
- To characterize the natural history of classic Hodgkin lymphoma in very young patients.
Main Methods:
- Retrospective analysis of 135 very young patients diagnosed with classic Hodgkin lymphoma.
- Statistical evaluation to identify the best age cutoff for risk stratification.
- Comparison of event-free survival (EFS) and progression-free survival (PFS) between age groups.
Main Results:
- An age cutoff of 7 years was identified as optimal for distinguishing risk groups.
- Significantly better EFS (p=.0451) and PFS (p=.00921) were observed in patients younger than 7 years.
- Ten-year overall survival (OS) rates were 97.0% for younger patients versus 92.5% for older patients (p=.0448).
Conclusions:
- While younger patients with cHL show better outcomes, age is not an independent prognostic factor.
- The improved prognosis in younger children appears linked to more favorable initial disease characteristics.
Abstract:
Many studies have reported a more favorable outcome in younger patients with Hodgkin lymphoma (HL). The aims of this study were to find an appropriate age cutoff able to identify low-risk children and to describe the natural history of 135 very young patients affected by classic HL (cHL). The best age cutoff was identified at 7 years of age. EFS (p = .0451) and PFS (p = .00921) were significantly better in the group of younger patients. The OS rate at 10 years was 97.0% in the younger group and 92.5% in the older one (p = .0448). However, age was not found to be an independent prognostic factor in multivariate analysis and the better prognosis in younger patients seems to be related to more favorable disease characteristics at presentation.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Classical Conditioning
Ivan Pavlov observed that dogs...
Principles of Classical Conditioning
During the...

